GMC number: 7081891

Year & location of first qualification: 2010, Cardiff University

Specialty: Breast Surgery

Clinical interests: Breast conserving surgery including therapeutic mammoplasty and chest wall perforator flaps

Secretary: Sania Robinson

Secretary phone number: 0117 414 7000

GMC number: 7427258 

Year & location of first qualification: 2013 University College London

Specialty: Geriatrics

Clinical interests: Acute frailty, community geriatrics 

Secretary: Karen Barry and Michaela Perry

Secretary phone number: 0117 414 6643

Dr Watts is a consultant geriatrician specialising in caring for older people in the community, through the transition into hospital and during the initial hospital stay. 

GMC number: 7085063

Year & location of first qualification: 2010, Barts and the London School of Medicine and Dentistry

Specialty: Anaesthesia

Secretary: Helen Pearce

Secretary phone number: 0117 414 5114

Bachelor of Medicine
Bachelor of Surgery
Member of the Royal Colleges of Physicians of the United Kingdom
Fellow of the Royal College of Anaesthetists
 

GMC number: 7304038

Year & location of first qualification: 2012 University College London

Specialty: Acute Internal Medicine and General Internal Medicine

Secretary: Lisa Williams

Secretary phone number: 0117 414 1411

MRCP
 

GMC number: 7016130

Year & location of first qualification: 2008, Oxford University

Specialty: Anaesthetics

Clinical interests: Perioperative allergy, vascular anaesthesia, obstetrics

Secretary: Anaesthetic Department

GMC number: 6089173

Year & location of first qualification: 2000 - Lusaka, Zambia

Specialty: Microbiology

Clinical interests: Antimicrobial Stewardship

Secretary: Josephine Poad

Secretary phone number: 0117 414 6273 

MRCP, FRCPath

Our dynamic team includes an array of clinical researchers and skilled support staff that look after North Bristol NHS Trust’s broad set of research specialities.

If you want to find out more about the research we do, or have any other related query, simply get in touch with the relevant team. 

Executive Team

Director of Research: Professor Fergus Caskey
Deputy Director of Research: email: helen.lewis-white@nbt.nhs.uk

Research Communications

Research Communications team contact details:
Research.Communications@nbt.nhs.uk

Finance

Research Finance team contact details:
ResearchFinance@nbt.nhs.uk

Operations

Research Sponsorship Team contact details:
ResearchSponsor@nbt.nhs.uk 

Research Facilitation Team contact details:
Research@nbt.nhs.uk

Infrastructure

Research Infrastructure Manager: Angelo Micciche

Development & Grants

Research Grants & Development team contact details: 
researchgrants@nbt.nhs.uk

While some types of clinical research are based on examining and observing people with specific health conditions, certain others require broader comparisons.

In some cases, such as with the vaccine trials for COVID-19 or our ongoing maternity research, an open call will be shared with the public to try and recruit large numbers of participants. These are often for UK-wide studies, aiming to find out what treatments are likely to be helpful for the largest amount of people.

Why take part?

Clinical research is essential for developing better treatments and improving healthcare. Many patients take part in clinical research to help us to find the best ways to:

• Provide the best advice and treatments for people.
• Share knowledge and learning.
• Improve patient care.

Even though you may be interested in taking part, we have to be sure that you fit the narrow criteria for that study and are eligible. This might take into account your current health status, history, age, gender, etc. Eligibility is often quite specific to ensure that the people who take part are not exposed to avoidable risks.

Should you be interested in getting involved in our research in the absence of an open call, you may find yourself well suited to one of our Public Involvement Groups. These are an opportunity to share your experiences, regardless of your health status, to help further the research that takes place at NBT.

To see the full range of research that is currently taking place across the hospital, please visit Our Research pages.

GMC Number: 7073714

Year of first qualification: 2010, University of Oxford

Specialty: Diabetes & Endocrinology and General Internal Medicine (dual accredited)

Clinical interest: insulin pump therapy and diabetes technology, pituitary disease, antenatal diabetes and endocrinology, education
 

Our new Coagulation Screening and Haematology platforms are live.

Whilst the majority of reference ranges will stay the same, some are quite different. Specific protocols and reference range information is displayed below.

For Special Coagulation tests (Thrombophilia, Lupus Anticoagulant and Factor Assays), relevant comments will be added to results as appropriate.

Please note that Paediatric ranges have not changed.

Haemoglobinopathy change in platform:

As of as of 18/12/2023, the first line haemoglobinopathy testing analytical method has changed. It is approved for use in sickle cell and thalassaemia (SCT) screening programme and has been verified in-house at NBT

The new reference range will therefore start at 90% (change from 80%). The previous method separated some HbA fractions, which no longer applies to the new method, but this has no impact on the interpretation of results. 

HbA2 values are comparable across platforms and reference ranges and interpretation have not changed.

HbF less than 0.3% is not detectable on the new analyser and results less than this will therefore be reported as HbF <0.3%.

There will be no changes to the way that haemoglobin variants and thalassaemias (carriers and disease) are reported.

Test accreditation

We are updating both our test information pages Test Information and the quality section Pathology Accreditation and Compliance Status with details of assays affected.

All the tests, which were previously accredited by UKAS, will be going under an Extension to Scope process. However, please be assured that the quality of our services will remain the same.

If you have any concerns or queries, please contact us (https://www.nbt.nhs.uk/severn-pathology/pathology-services/haematology/contact-haematology).